However, in this study, we could not find significant association between TACC2 status and AR LI in breast carcinoma cases (Table 1) or induction of TACC2 mRNA expression by DHT treatment in breast carcinoma cells (Fig. 4A, B). The gene discussed is TACC2; the disease is breast carcinoma.